Atazanavir

In the US, Atazanavir (atazanavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

• Atazanavir


• Atazanavir Sulfate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE08

CAS registry number (Chemical Abstracts Service)

0198904-31-3

Chemical Formula

C38-H52-N6-O7

Molecular Weight

704

Therapeutic Category

Antiviral agent, HIV protease inhibitor

Chemical Names

(3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydoxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester

(3S,8S,9S,12S)-9-benzyl-3,12-bis(1,1-diméthyléthyl)-8-hydroxy-4,11-dioxo-6-[4-(pyridin-2-yl)benzyl]-2,5,6,10,13-pentaazatétradécanedioate de diméthylene (WHO)

(S)-{1-[N'-[(2S,3S)-2-Hydroxy-3-((S-methoxycarbonylamino-3,3-dimethylbutyrylamino)-4- phenylbutyl]-N'-(4-pyridin-2-ylbenzyl)hydrazinocarbonyl]-2,2-dimetehylethylpropyl} carbaminsäuremethylester (IUPAC)

Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate (WHO)

Foreign Names

• Atazanavirum (Latin)
• Atazanavir (German)
• Atazanavir (French)
• Atazanavir (Spanish)

Generic Names

• Atazanavir (OS: BAN)
• BMS 232632 (IS: Bristol-Myers)
• CGP 73547 (IS: Novartis)
• Latazanavir (IS)
• Zrivida (IS)
• Atazanavir Sulfate (OS: USAN)
• Atazanavir Sulphate (OS: BAN)
• BMS-232632-05 (IS: Bristol-Myers)

Brand Names

• Reyataz
  Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Russian Federation



• Atazanavir
  Emcure, United States



• Reyataz
  Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb Phar, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.